ArticleBMC genomics2025
Probability of stealth multiplets in sample-multiplexing for droplet-based single-cell analysis.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne of the technical limits of droplet-based single-cell RNA sequencing (scRNA-seq) is the presence of multiplets, i.e. droplets that capture multiple cells. Sample-multiplexing scRNA-seq (mx-scRNA-seq) enables us to evaluate large numbers of different samples or experiments simultaneously by reducing the occurrence of undetectable multiplets. However, there is still a possibility of hidden multiplets among what appear to be singlets, for which we introduce the term stealth multiplets, and their probability is yet to be quantitatively examined.
resultsWe developed a simple theoretical model to predict four classes of possible multiplets in mx-scRNA-seq: Homogeneous stealth, partial stealth, multilabelled, and unlabelled. We estimated the probability of each class and have found that the partial stealth multiplet, which has been previously overlooked, may impact the results of the whole dataset, particularly when the labelling process or demultiplexing is suboptimal. Also, we demonstrated their presence in real mx-scRNA-seq datasets both in oligonucleotide-barcode demultiplexing and genotype-based demultiplexing.
conclusionOur results show the importance of optimising the labelling procedure and choosing the most suitable demultiplexing algorithm. We thus offer a theoretical basis to estimate the probability of each type of multiplet to ensure the integrity of mx-scRNA-seq.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.